Restenosis, the recurrence of narrowing of the arteries after stenting, is a common risk of this endovascular treatment. There are no well-defined guidelines to treat restenosis, but recent studies have shown excellent results with drug-eluting balloon angioplasty in coronary and femoral artery stents. However, few studies have focused on the carotid arteries, which take blood to the neck and head.
InVivo Therapeutics has announced that the first subject has been enrolled in the pilot study of its Neuro-Spinal Scaffold for the treatment of complete traumatic spinal cord injury at the Barrow Neurological Institute at St Joseph’s Hospital and Medical Center in Phoenix, USA. The objective of the pilot study is to evaluate the safety and feasibility of the Neuro-Spinal Scaffold as well as to gather preliminary evidence of effectiveness.
November 6, 2014—Lazarus Effect, Inc. announced that the company’s Lazarus Cover accessory device has received European CE Mark approval. The device is a nitinol mesh cover that surrounds a retriever device and captured material during removal from a blood vessel. Lazarus Effect plans to launch the Lazarus Cover in Europe during the first quarter of 2015.
November 4, 2014—VIVA Physicians, Inc. announced that Christopher J. Kwolek, MD, presented findings from the ROADSTER pivotal trial during a late-breaking trials session at the VIVA 2014: Vascular InterVentional Advances meeting in Las Vegas, Nevada. ROADSTER is a prospective, multicenter, investigational device exemption study designed to evaluate the safety and effectiveness of a novel hybrid carotid revascularization procedure using Silk Road Medical, Inc.’s Enroute transcarotid neuroprotection system (NPS).
November 4, 2014—VIVA Physicians, Inc. announced that D. Christopher Metzger, MD, presented findings from the CANOPY trial during a late-breaking trials session at the VIVA 2014: Vascular InterVentional Advances meeting in Las Vegas, Nevada. CANOPY is a prospective, multicenter, nonrandomized, single-arm, postapproval study to evaluate the safety and effectiveness of the RX Acculink carotid stent system (Abbott Vascular) in patients at standard risk for adverse events from carotid endarterectomy (CEA). CANOPY was mandated by the US Food and Drug Administration as a follow-up study to the CREST trial.
InspireMD has announced positive results from the CARENET (Carotid embolic protection study using microNET) trial for its CGuard embolic protection system. This trial demonstrates that the MicroNet covered CGuard may offer important clinical benefits for patients undergoing carotid artery stenting.
Medtronic has announced the launch of the Kyphon Express II Balloon Kyphoplasty Platform, which includes the next generation Kyphon Cement Delivery System. This new platform is the latest advancement in the Kyphon Balloon Kyphoplasty technology for the treatment of vertebral compression fractures.
New data presented at the Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting in (28 –31, Colorado Springs, USA) helps prove that written care protocols can significantly improve the overall emergency care pathway for stroke.
Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, has announced the launch of the Envoy DA XB distal access guiding catheter and the 7F Envoy guiding catheter for neurovascular procedures
New technology in the form of a magnetically-assisted remote-controlled catheter (MARC) which could allow physicians to see and assess brain tissue more clearly while treating a stroke may hold promise, according to study authors who released their findings at the Society of NeuroInterventional Surgery (SNIS) 11th Annual Meeting in Colorado Springs, USA20140801
Silk Road Medical has announced the completion of enrolment in its pivotal ROADSTER study. The trial was the first of its kind to study the treatment of carotid artery stenosis by placing a stent via direct access to the common carotid artery in the neck in an entirely new minimally invasive procedure. The device under study is the company’s Enroute transcarotid neuroprotection system which incorporates proven surgical principles to protect the brain from a stroke during carotid angioplasty and stenting, and features a mechanism to divert dangerous debris away from the brain by temporarily reversing blood flow. Data from the trial will be used to support 510(k) clearance of the Enroute transcarotid neuroprotection system as well as pre-market approval of the Enroute transcarotid stent system
For the first time ever, a paralysed man has moved his fingers and hand with his own thoughts after an electronic neural bypass for spinal cord injuries that reconnects the brain directly to muscles, allowing voluntary and functional control of a paralysed limb. This innovation comes from a partnership between The Ohio State University Wexner Medical Center and Battelle.
The United States Preventive Services Task Force recommends against screening for asymptomatic carotid artery stenosis in the general adult population, according to a recommendation statement being published in Annals of Internal Medicine.
Larry Ambrose was diagnosed as having a stroke a few days after he woke up one night, wandered into his kitchen and couldn´t read the time on his microwave. Ambrose, like 25 percent of all stroke patients, experienced a cryptogenic ischemic stroke, meaning physicians were unable to determine a cause.
In a new study published online in the Journal of the American Heart Association, researchers at Columbia Engineering report that they have identified a new component of the biological mechanism that controls blood flow in the brain. Led by Elizabeth M. C. Hillman, associate professor of biomedical engineering, the team has demonstrated, for the first time, that the vascular endothelium plays a critical role in the regulation of blood flow in response to stimulation in the living brain.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos